Literature DB >> 3889171

Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis.

J L Shenep, R P Barton, K A Mogan.   

Abstract

To evaluate the role of antibiotic class in the rate of liberation of endotoxin during therapy for sepsis caused by gram-negative bacteria, we obtained serial blood samples from rabbits with sepsis caused by Escherichia coli and treated with chloramphenicol, gentamicin, or moxalactam. The concentrations of viable bacteria, free endotoxin, and total endotoxin in each blood sample were measured. In rabbits treated with chloramphenicol, the geometric mean levels of free endotoxin remained proportional to the geometric mean levels of bacteremia, a result indicating the absence of antibiotic-induced endotoxin liberation. In contrast, levels of free endotoxin increased rapidly while levels of bacteremia declined after treatment with gentamicin or moxalactam, a result indicating antibiotic-induced release of endotoxin. Despite similar rates of bacterial killing, mean levels of free endotoxin were as much as 20-fold higher in rabbits treated with moxalactam than in paired rabbits receiving gentamicin (P less than .05). These results indicate that endotoxin liberation during therapy for sepsis caused by gram-negative bacteria is dependent upon the class of antibiotic administered and is not necessarily correlated with the rate of bacterial killing.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889171     DOI: 10.1093/infdis/151.6.1012

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  47 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Infectious disease therapy in the 1990s. Where are we heading?

Authors:  M Rozenberg-Arska; M R Visser
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

3.  Dephosphorylation of endotoxin by alkaline phosphatase in vivo.

Authors:  K Poelstra; W W Bakker; P A Klok; J A Kamps; M J Hardonk; D K Meijer
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

4.  Antibiotic-induced release of endotoxin in chronically bacteriuric patients.

Authors:  J C Hurley; W J Louis; F A Tosolini; J B Carlin
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

5.  In vitro reduction of endotoxin concentrations with the 5S fragment of immunoglobulin G.

Authors:  D Xuan; D P Nicolau; P R Tessier; L Bow; R Quintiliani; C H Nightingale
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

6.  Endotoxemia as a diagnostic tool for patients with suspected bacteremia caused by gram-negative organisms: a meta-analysis of 4 decades of studies.

Authors:  James C Hurley; Piotr Nowak; Lars Öhrmalm; Charalambos Gogos; Apostolos Armaganidis; Evangelos J Giamarellos-Bourboulis
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

7.  Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide.

Authors:  R L Danner; K A Joiner; M Rubin; W H Patterson; N Johnson; K M Ayers; J E Parrillo
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

8.  The anti-lipid A antibody HA-1A binds to rough gram-negative bacteria, fixes complement and facilitates binding to erythrocyte CR1 (CD35).

Authors:  M Tonoli; K A Davies; P J Norsworthy; J Cohen; M J Walport
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

9.  Increased renal uptake of gentamicin in endotoxemic rats receiving concomitant thromboxane A2 antagonist therapy.

Authors:  M Tardif; Y Bergeron; D Beauchamp; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

Review 10.  Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?

Authors:  Lars Steinstraesser; Ursula M Kraneburg; Tobias Hirsch; Marco Kesting; Hans-Ulrich Steinau; Frank Jacobsen; Sammy Al-Benna
Journal:  Int J Mol Sci       Date:  2009-09-09       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.